PT. Inertia Utama Executive and Leadership Team

Raymond Tjandrawinata, the President & Commissioner at PT. Inertia Utama, provides strategic oversight and governance for the company's operations in the pharmaceutical sector. This executive leadership role involves guiding the overall direction and ensuring adherence to corporate policies and ethical standards. Raymond Tjandrawinata champions the company's mission by setting high-level objectives and monitoring progress towards achieving them. The President & Commissioner works closely with the Board of Commissioners to review financial performance and approve major strategic initiatives. This position is crucial for maintaining stakeholder confidence and ensuring sustainable growth. By offering expert guidance, Raymond Tjandrawinata influences key decisions related to market expansion and product development. The President & Commissioner's ultimate responsibility lies in safeguarding the company's long-term viability and enhancing its reputation within the Indonesian pharmaceutical landscape.

Hery Sutanto, the President & Director at PT. Inertia Utama, leads the company's strategic vision and operational execution within the pharmaceutical industry. This dual role encompasses setting ambitious business objectives and ensuring their effective implementation across all departments. Hery Sutanto drives market penetration and revenue growth by identifying new opportunities and strengthening existing business relationships. The President & Director oversees the company's financial health, managing budgets and resource allocation to support strategic priorities. This leadership position requires close collaboration with the Board of Directors to foster innovation and maintain competitive advantage. By directing key initiatives, Hery Sutanto ensures PT. Inertia Utama remains at the forefront of pharmaceutical advancements. The President & Director's commitment is to enhance the company's impact and deliver value to customers and stakeholders in Indonesia.

Wimala Widjaja, the Chief Information Officer at PT. Inertia Utama, directs the company's technology strategy and digital transformation initiatives. Overseeing all IT infrastructure, Wimala Widjaja ensures robust cybersecurity measures and data integrity, critical for operations within the pharmaceutical sector. This leadership role involves managing the implementation of advanced technological solutions that support research, development, and production processes. The Chief Information Officer drives efficiency by optimizing software systems and digital workflows, directly impacting the company's operational agility and market responsiveness. Strategic planning for future technology adoption falls under this purview, ensuring PT. Inertia Utama maintains a competitive edge through technological advancement. The Chief Information Officer also collaborates with other department heads to align technology investments with overarching business objectives, facilitating seamless integration across all functional areas.

Ferry Soetikno, the Direktur at PT. Inertia Utama, oversees critical operational functions and strategic execution within the pharmaceutical industry. This leadership position involves managing day-to-day business activities and ensuring alignment with the company's long-term goals. Ferry Soetikno drives operational excellence by optimizing production workflows and supply chain management, essential for delivering pharmaceutical products efficiently. The Direktur plays a key part in fostering a culture of quality and compliance, adhering to stringent industry regulations. This role requires close collaboration with other executive leaders to identify growth opportunities and mitigate business risks. By directing cross-functional teams, Ferry Soetikno ensures that PT. Inertia Utama consistently meets its production targets and market demands. The Direktur's focus remains on enhancing operational performance and contributing to the company's overall success in the Indonesian market.